SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2026)
SAB Biotherapeutics (SABS) posted Exchange Rate Effect of $14729.0 for Q1 2026, up 103.7% on a QoQ basis from -$397861.0 in Q4 2025, and down 65.34% year-over-year from $42500.0 in Q1 2025.
SAB Biotherapeutics (SABS) Exchange Rate Effect (2024 - 2026) Analysis & Trends
SAB Biotherapeutics' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $14729.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 65.34% year-over-year to $14729.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$241268.0 (down 41.57% YoY) and the FY2025 annual result came in at -$213497.0, up 11.48% from the prior year.
- Exchange Rate Effect was $14729.0 for Q1 2026 at SAB Biotherapeutics, up from -$397861.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $179401.0 in Q2 2025 and bottomed at -$397861.0 in Q4 2025.
- A 3-year average of -$48885.1 and a median of $14729.0 in 2026 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 534.31% in 2025, while the deepest fall reached 178.96% in 2025.
- SAB Biotherapeutics' Exchange Rate Effect stood at -$288748.0 in 2024, then slumped by 37.79% to -$397861.0 in 2025, then surged by 103.7% to $14729.0 in 2026.
- Business Quant data shows SABS's Exchange Rate Effect at $14729.0 in Q1 2026, -$397861.0 in Q4 2025, and -$37537.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | 14,729.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,729.00 |
| Mar 31, 2026 | 14,729.00 |
| Dec 31, 2025 | -397,861.00 |
| Dec 31, 2025 | -397,861.00 |
| Sep 30, 2025 | -37,537.00 |
| Sep 30, 2025 | -37,537.00 |
| Jun 30, 2025 | 179,401.00 |
| Jun 30, 2025 | 179,401.00 |
| Mar 31, 2025 | 42,500.00 |
| Mar 31, 2025 | 42,500.00 |
| Dec 31, 2024 | -288,748.00 |
| Dec 31, 2024 | -288,748.00 |
| Sep 30, 2024 | 47,537.00 |
| Sep 30, 2024 | 47,537.00 |
| Jun 30, 2024 | 28,283.00 |
| Jun 30, 2024 | 28,283.00 |
| Mar 31, 2024 | -28,270.00 |
| Mar 31, 2024 | -28,270.00 |